A036180 Stock Overview
Engages in the development, manufacturing, and sale of bio-related antibodies and biotechnology solutions in Korea, the United States, Asia, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
GW Vitek CO.,LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩577.00 |
| 52 Week High | ₩855.00 |
| 52 Week Low | ₩429.00 |
| Beta | 1.09 |
| 1 Month Change | 0% |
| 3 Month Change | 4.91% |
| 1 Year Change | -20.30% |
| 3 Year Change | -78.27% |
| 5 Year Change | -86.41% |
| Change since IPO | -99.91% |
Recent News & Updates
GW Vitek CO.,LTD.'s (KOSDAQ:036180) Shares Bounce 27% But Its Business Still Trails The Industry
Sep 09
Insufficient Growth At GW Vitek CO.,LTD. (KOSDAQ:036180) Hampers Share Price
May 30Shareholder Returns
| A036180 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 0% | -5.3% | -2.1% |
| 1Y | -20.3% | 33.7% | -9.0% |
Return vs Industry: A036180 underperformed the KR Life Sciences industry which returned 38.3% over the past year.
Return vs Market: A036180 underperformed the KR Market which returned -4.9% over the past year.
Price Volatility
| A036180 volatility | |
|---|---|
| A036180 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 8.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A036180's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: Insufficient data to determine A036180's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 94 | Jae-Won Yang | www.gwvitek.com |
GW Vitek CO.,LTD., together with its subsidiaries, engages in the development, manufacturing, and sale of bio-related antibodies and biotechnology solutions in Korea, the United States, Asia, Europe, and internationally. It is also involved in supply of scientific equipment and related consumables; and provision of technology services. The company was formerly known as A-Frontier Co.,Ltd.
GW Vitek CO.,LTD. Fundamentals Summary
| A036180 fundamental statistics | |
|---|---|
| Market cap | ₩53.93b |
| Earnings (TTM) | -₩17.66b |
| Revenue (TTM) | ₩33.85b |
1.6x
P/S Ratio-3.1x
P/E RatioIs A036180 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A036180 income statement (TTM) | |
|---|---|
| Revenue | ₩33.85b |
| Cost of Revenue | ₩27.42b |
| Gross Profit | ₩6.43b |
| Other Expenses | ₩24.09b |
| Earnings | -₩17.66b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -188.93 |
| Gross Margin | 19.00% |
| Net Profit Margin | -52.16% |
| Debt/Equity Ratio | 35.6% |
How did A036180 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/06 15:18 |
| End of Day Share Price | 2024/09/09 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
GW Vitek CO.,LTD. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dongguen Kang | Yuanta Securities Korea Co., Ltd. |